GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WGS GeneDx Holdings

Trading 07-17 14:31:13 EDT

62.10

+0.41

+0.66%

High62.74	Low58.81	Vol272.18K
Open59.75	D1 Closing61.69	Amplitude6.36%
Mkt Cap1.84B	Tradable Cap1.17B	Total Shares29.68M
T/O16.61M	T/O Rate1.44%	Tradable Shares18.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":62.095,"timestamp":1784313069944,"preClose":61.69,"halted":0,"volume":272181,"delay":0,"changeRate":0.006565083481925776,"floatShares":18880677,"shares":29675547,"eps":-2.688733,"marketStatus":"Trading","change":0.405,"latestTime":"07-17 14:31:13 EDT","open":59.75,"high":62.735,"low":58.8118,"amount":16610995.217544,"amplitude":0.063595,"askPrice":62.21,"askSize":18,"bidPrice":62.04,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.688733,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1784318400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":61.69,"preHourTrading":{"tag":"盘前","latestPrice":59.43,"preClose":61.69,"latestTime":"09:28 EDT","volume":290,"amount":17898.25944,"timestamp":1784294905069,"change":-2.26,"changeRate":-0.036635,"amplitude":0.044254},"postHourTrading":{"tag":"盘后","latestPrice":61.0715,"preClose":61.69,"latestTime":"19:52 EDT","volume":3001,"amount":184759.3308,"timestamp":1784245970925,"change":-0.6185,"changeRate":-0.010026,"amplitude":0.013877},"volumeRatio":0.471688,"impliedVol":1.0412,"impliedVolPercentile":0.7849},"requestUrl":"/m/hq/s/WGS/wiki","defaultTab":"wiki","newsList":[{"id":"2652424499","title":"Genedx to Report Q2 2026 Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2652424499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652424499?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:06","pubTimestamp":1784232375,"startTime":"0","endTime":"0","summary":"GeneDx to report Q2 2026 results after market close, host conference callGeneDx (WGS) schedules Q2 2026 financial results release for Aug. 3, 2026.Management conference call set for Aug. 3, 2026 at 4:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL5CvXT1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650155631","title":"How Investors Are Reacting To GeneDx Holdings (WGS) Class Actions Over Fabric Impairment And Guidance Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2650155631","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650155631?lang=en_us&edition=fundamental","pubTime":"2026-07-11 11:38","pubTimestamp":1783741092,"startTime":"0","endTime":"0","summary":"In the past few weeks, multiple law firms have launched or promoted securities class actions against GeneDx Holdings, alleging that prior statements about the Fabric Genomics acquisition and its financial impact were false or misleading, particularly after the company disclosed a US$31.2 million impairment tied to Fabric alongside missed revenue estimates and reduced full-year guidance on May 4, 2026.\nThese lawsuits focus on whether GeneDx adequately disclosed Fabric’s business challenges...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/how-investors-are-reacting-to-genedx-holdings-wgs-class-acti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/how-investors-are-reacting-to-genedx-holdings-wgs-class-acti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QTOC","WGS","BK4196","CHAT","VTHR","AIPO","ARTY","ISBC","BK4211","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647081377","title":"Genedx Holdings is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2647081377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647081377?lang=en_us&edition=fundamental","pubTime":"2026-06-29 22:17","pubTimestamp":1782742620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings(END) Dow Jones NewswiresJune 29, 2026 10:17 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647022343","title":"Is GeneDx (WGS) Elevating Execution Risk or Opportunity With Its New Genomics-Focused President?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647022343","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647022343?lang=en_us&edition=fundamental","pubTime":"2026-06-29 03:09","pubTimestamp":1782673781,"startTime":"0","endTime":"0","summary":"GeneDx Holdings recently appointed Mark Gardner as President, effective June 15, 2026, reporting to CEO Katherine Stueland and leading the company’s commercial and operations teams to strengthen execution and scale genomic medicine offerings.\nGardner’s background running genomics and oncology businesses at Quest Diagnostics, OmniSeq, Thermo Fisher Scientific and Life Technologies adds deep operational and precision-medicine expertise to GeneDx’s leadership bench.\nWe’ll now examine how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/is-genedx-wgs-elevating-execution-risk-or-opportunity-with-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/is-genedx-wgs-elevating-execution-risk-or-opportunity-with-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645858300","title":"GeneDx Holdings Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2645858300","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645858300?lang=en_us&edition=fundamental","pubTime":"2026-06-24 00:28","pubTimestamp":1782232080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 23, 2026 12:28 ET (16:28 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645367398","title":"GeneDx holds annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645367398","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645367398?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:36","pubTimestamp":1782218194,"startTime":"0","endTime":"0","summary":"GeneDx Holdings held its annual shareholder meeting on June 18, 2026.Shareholders backed the selection of a Class II director for a three-year term; the vote authorized the appointment but did not itself implement board service.Ernst & Young was ratified as independent auditor for the fiscal year ending Dec. 31, 2026; the vote endorsed the appointment rather than constituting the audit.Shareholders supported holding future advisory votes on executive pay every year; the result signaled preference but did not set a binding schedule.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL9z5G3h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645002427","title":"GeneDx Holdings Corp : Piper Sandler Raises Target Price to $63 From $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2645002427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645002427?lang=en_us&edition=fundamental","pubTime":"2026-06-23 11:41","pubTimestamp":1782186090,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nFWN42U0I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644670837","title":"GeneDx President Mark A. Gardner files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2644670837","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644670837?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:11","pubTimestamp":1781640684,"startTime":"0","endTime":"0","summary":"GeneDx named Mark A. Gardner as president in an initial Form 3 beneficial ownership filing dated June 15.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL7ZXfhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643578297","title":"GeneDx appoints Gardner as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2643578297","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643578297?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:38","pubTimestamp":1781613490,"startTime":"0","endTime":"0","summary":"GeneDx (WGS) announced the appointment of Mark Gardner as President, effective June 15, 2026. Reporting to Katherine Stueland, Chief Executive Offi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genedx-appoints-gardner-as-president-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genedx-appoints-gardner-as-president-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643752463","title":"GeneDx names former Quest executive Mark Gardner as president","url":"https://stock-news.laohu8.com/highlight/detail?id=2643752463","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643752463?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:30","pubTimestamp":1781613046,"startTime":"0","endTime":"0","summary":"GeneDx appointed Mark Gardner as president, effective June 15, 2026.He will run commercial operations, aiming to tighten execution, scale the business, expand its position in genomic medicine.Gardner previously led molecular genomics and oncology as senior vice president at Quest Diagnostics.He was CEO of OmniSeq before its acquisition by Labcorp.Earlier roles included senior leadership posts at Thermo Fisher Scientific, Life Technologies.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL7NhfN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU2125909247.SGD","LU2764263039.SGD","LU1983299246.USD","LU0070302665.USD","BK4534","BK4548","LU2125910179.SGD","LU0823417653.USD","LU1670628061.USD","LU1854103824.USD","LU2264538146.SGD","WGS","LU1670627923.USD","LU0316494557.USD","LU0006061336.USD","LU2112291526.USD","LU0048573561.USD","DGX","TMO","BK4535","LU0320765489.SGD","BK4581","LU2543165471.USD","LU0061474960.USD","IE00BJT1NW94.SGD","IE00B19Z9505.USD","IE0009355771.USD","LU1815333072.USD","IE00BQXX3C00.GBP","LU1923622614.USD","LU2237438978.USD","IE0034235188.USD","LU0251142724.SGD","LU0096362180.USD","LU0882574055.USD","LH","LU2506951958.HKD","LU0957791311.USD","LU2506951875.HKD","BK4583","LU2360108059.USD","LU2041044095.USD","BK4567","LU0122379950.USD","LU1720051108.HKD","IE00BQXX3D17.EUR","LU2211815571.USD","LU1061106388.HKD","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643752110","title":"GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2643752110","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643752110?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:30","pubTimestamp":1781613001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUAB5GKDD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642749067","title":"GeneDx Holdings Corp. Faces Federal Securities Lawsuit After 49% Stock Plunge Tied to Fabric Acquisition Allegations","url":"https://stock-news.laohu8.com/highlight/detail?id=2642749067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642749067?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:50","pubTimestamp":1781038217,"startTime":"0","endTime":"0","summary":"GeneDx Holdings Corp. (NASDAQ: WGS) is facing a federal securities lawsuit alleging that the company and its top executives misled investors about ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/genedx-holdings-corp-faces-federal-securities-lawsuit-after-49-stock-plunge-tied-to-fabric-acquisition-allegations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/genedx-holdings-corp-faces-federal-securities-lawsuit-after-49-stock-plunge-tied-to-fabric-acquisition-allegations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLTW","WGS","QID","US30Y.BOND","GPIQ","QQQA","US12M.BOND",".IXIC","QQQE","TMF","NQmain","QLD","US5Y.BOND","ONEQ","US7Y.BOND","MNQmain","FTEC","TQQQ","TQQY","US10Y.BOND","QQQM","QDTE","QQQY","IYW","SQQQ","QQQJ","US3Y.BOND","PSQ","TECS","US2Y.BOND","BK4196","JEPQ","TLT","NDX","NVIW.SI","US6M.BOND","QQQ","QYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642642491","title":"Analysts Are Bullish on Top Healthcare Stocks: Harrow Health (HROW), GeneDx Holdings (WGS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642642491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642642491?lang=en_us&edition=fundamental","pubTime":"2026-06-10 00:50","pubTimestamp":1781023809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Harrow Health (HROW) and GeneDx Holdings (WGS) with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-harrow-health-hrow-genedx-holdings-wgs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-harrow-health-hrow-genedx-holdings-wgs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS","HROW","BK4557","BK4007","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642829432","title":"Casdin Capital acquires USD 11.11 million of GeneDx common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642829432","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642829432?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:25","pubTimestamp":1780953955,"startTime":"0","endTime":"0","summary":"Casdin Capital reported open-market purchases of 200,000 GeneDx Holdings Class A shares at prices ranging from $52.86 to $56.44.Casdin Partners Master Fund’s indirect stake rose to 3,707,164 shares following the trades.Eli Casdin, managing member, also reported direct ownership of 20,517 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL9vqhLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Casdin Capital acquires USD 11.11 million of GeneDx common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640947477","title":"A Look At GeneDx Holdings (WGS) Valuation After Recent Share Price Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2640947477","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640947477?lang=en_us&edition=fundamental","pubTime":"2026-06-03 01:22","pubTimestamp":1780420977,"startTime":"0","endTime":"0","summary":"With no single headline event driving GeneDx Holdings (WGS) today, the stock’s recent moves invite a closer look at how its genetic testing business and financial profile are lining up for investors.\nSee our latest analysis for GeneDx Holdings.\nRecent trading has been choppy, with a 7 day share price return of about 9.9% following a 30 day share price decline of roughly 20.5%. The year to date share price return is down around 60.7%, and the 3 year total shareholder return remains very large,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-recent-share-p-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-recent-share-p-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638854052","title":"GeneDx to present at Goldman Sachs Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2638854052","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638854052?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:05","pubTimestamp":1779825941,"startTime":"0","endTime":"0","summary":"GeneDx will attend the Goldman Sachs 47th Annual Global Healthcare Conference in Miami on June 8-10, 2026.Management is scheduled for a fireside chat on June 9, 2026 at 8:00 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire  on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL37psxb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0742534661.SGD","IE0034235188.USD","BK4533","LU2237443978.SGD","BK4585","LU2237443465.HKD","WGS","LU1894683348.USD","LU2750360997.AUD","LU0345770993.USD","LU0868494708.USD","LU2237443895.HKD","LU2471134796.USD","IE00B19Z3581.USD","LU2237443382.USD","LU2265009873.SGD","BK4127","BK4550","LU1804176565.USD","LU1868836757.USD","BK4516","LU2471134952.CNY","LU0048573561.USD","IE00B19Z3B42.SGD","IE0002270589.USD","IE00BFXG1179.USD","LU0096364046.USD","LU1868836591.USD","LU2237438978.USD","LU2237443622.USD","LU0061475181.USD","BK4196","LU0251131958.USD","LU0251142724.SGD","BK4504","LU1868837136.USD","LU2237443549.SGD","IE0004091025.USD","LU1868836914.USD","LU2471134523.USD","IE0004086264.USD","BK4552","BK4588","LU1894683264.USD","LU2471134879.HKD","LU0345770308.USD","LU1791807156.HKD","GSX","LU0106831901.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637734768","title":"13D Filings -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2637734768","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637734768?lang=en_us&edition=fundamental","pubTime":"2026-05-23 06:23","pubTimestamp":1779488580,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from May 14 through May 20, 2026. Source: VerityData. Ashland  Standard Investments raised its stake in the specialty chemicals company to 4,095,001 shares. Standard Investments did so through the purchase of 490,000 Ashland shares from May 12 through May 15 at per share prices ranging from $54.43 to $57.82.Following the latest purchases, Standard Investments owns an 8.9% stake in Ashland's outstanding stock. Shares of Ashland have lost approximately 6.5% of their value in 2026.GeneDx Holdings CMLS Holdings raised its stake in the health-intelligence company to 5,356,767 shares. CMLS Holdings did so through the purchase of 351,273 GeneDx shares from May 13 through May 15 at per share prices ranging fr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SATL","LU1169589451.USD","BK4023","ASH","BK4588","BK4560","BK4109","ALKT","LU0348723411.USD","BK4196","BK4187","LU2463526074.USD","BK4585","LU1169590202.USD","WGS","DT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637808260","title":"Major Insider Move Signals Growing Confidence in GeneDx Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2637808260","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637808260?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:11","pubTimestamp":1779329470,"startTime":"0","endTime":"0","summary":"New insider activity at GeneDx Holdings ( ($WGS) ) has taken place on May 20, 2026. Director Casdin Capital, LLC has made a significant move in Gen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-genedx-holdings-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-genedx-holdings-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637871709","title":"Casdin Capital acquires 500,000 GeneDx shares valued at $21,367,516.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2637871709","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637871709?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:46","pubTimestamp":1779320773,"startTime":"0","endTime":"0","summary":"Casdin Capital, a director and 10% owner of GeneDx Holdings, reported open-market purchases totaling 500,000 Class A common shares.The buys were executed at weighted-average prices of $42.55, $42.6, and $43.81.Holdings reported indirectly through the Casdin Partners Master Fund rose to 3,507,164 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL8pbrVs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Casdin Capital acquires 500,000 GeneDx shares valued at $21,367,516.50","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636016302","title":"A Look At GeneDx Holdings (WGS) Valuation After Q1 2026 Reset And Securities Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2636016302","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636016302?lang=en_us&edition=fundamental","pubTime":"2026-05-18 01:38","pubTimestamp":1779039489,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) has drawn attention after Q1 2026 results reported revenue of US$102.25 million, along with a significantly wider net loss and a reduced full-year revenue outlook.\nSee our latest analysis for GeneDx Holdings.\nThe sharp reset in guidance and the securities investigation have coincided with pressure on GeneDx's stock, with the 30 day share price return down 38.22% and the year to date share price return down 69.20%. At the same time, the three year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-q1-2026-reset","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-q1-2026-reset","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":-0.111},{"period":"1month","weight":0.018},{"period":"3month","weight":-0.0647},{"period":"6month","weight":-0.4292},{"period":"1year","weight":-0.2334},{"period":"ytd","weight":-0.5257}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.0854},{"period":"1year","weight":0.2027},{"period":"ytd","weight":0.1009}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.104041},{"month":2,"riseRate":0.833333,"avgChangeRate":0.352675},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.143199},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.006052},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.040518},{"month":6,"riseRate":0.666667,"avgChangeRate":0.077733},{"month":7,"riseRate":0.666667,"avgChangeRate":0.098152},{"month":8,"riseRate":0.2,"avgChangeRate":-0.136267},{"month":9,"riseRate":0.2,"avgChangeRate":-0.072401},{"month":10,"riseRate":0.8,"avgChangeRate":0.18872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.130294},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.04765}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction